Low Use of Guideline-recommended Cardiorenal Protective Antihyperglycemic Agents in Primary Care: A Cross-sectional Study of Adults With Type 2 Diabetes-Reference-Cited by-同舟云学术

Low Use of Guideline-recommended Cardiorenal Protective Antihyperglycemic Agents in Primary Care: A Cross-sectional Study of Adults With Type 2 Diabetes

Published:2022-07 Issue:5 Volume:46 Page:487-494
ISSN:1499-2671
Container-title:Canadian Journal of Diabetes
language:en
Short-container-title:Canadian Journal of Diabetes

Author:

Marasinghe Dewdunee H.^ORCID,Butalia Sonia^ORCID,Garies Stephanie^ORCID,Drummond Neil,Kim James W.,Senior Peter A.

Funder

Diabetes Action Canada

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference45 articles.

1. Pharmacologic glycemic management of type 2 diabetes in adults;Can J Diabetes,2018

2. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: Systematic review analyses;Alzaid;Expert Rev Pharmacoecon Outcomes Res,2021

3. Health care costs associated with macrovascular, microvascular, and metabolic complications of type 2 diabetes across time: Estimates from a population-based cohort of more than 0.8 million individuals with up to 15 years of follow-up;Chen;Diabetes Care,2020

4. A retrospective observational population-based study to assess the prevalence and burden of illness of type 2 diabetes with an estimated glomerular filtration rate < 90 mL/min/1.73 m2 in Ontario, Canada;Rapattoni;Diabetes Obes Metab,2021

5. Relation between different measures of glycemic exposure and microvascular and macrovascular complications in patients with type 2 diabetes mellitus: An observational cohort study;van Wijngaarden;Diabetes Ther,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basal Insulin Initiation in Adults With Type 2 Diabetes Mellitus: A Retrospective Cohort Study Using Administrative Health Data in Alberta, Canada;Canadian Journal of Diabetes;2024-08

2. Real-world Use and Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Diabetes and Heart Failure: A Population-level Cohort Study in Alberta, Canada;Canadian Journal of Diabetes;2024-07

3. A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CAPTURE study;Diabetology & Metabolic Syndrome;2023-12-07

4. Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists;Annals of Hepatology;2023-11

5. Prescribing Trends of the Sodium–Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015–2021);Canadian Journal of Diabetes;2023-03